Company: OFIX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-061062
Chunk: 2

Company: Orthofix Medical Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 2
---
THOFIX ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2024 ARE AVAILABLE AT WWW.PROXYDOCS.COM/OFIX .

| Proxy Summary |

The summary highlights certain information about our business and 2024 performance, as well as other information in the proxy statement. This summary does not contain all of the information that you should consider, and we encourage you to read the entire proxy statement before voting. 2024 Business Highlights Notable financial results and operational accomplishments in 2024 include the following: • Net sales were $799.5 million, an increase of 7.1% on both a reported and constant currency basis • U.S. Spine Fixation net sales growth of 14.2% compared to prior year, driven by distribution expansion and further penetration in existing accounts • Bone Growth Therapies growth of 9.8% and Bone Growth Therapies Fracture growth of 13.0% compared to prior year • U.S. Spinal Implants, Biologics, and Enabling Technologies growth of 7.0% compared to prior year • U.S. Orthopedics net sales growth of 16.4% compared to prior year • Entered into record number of 7D FLASH TM Navigation System placements for full-year 2024 • Entered into new $275.0 million credit facility that replaces existing financing and further optimized our capital structure to support long-term profitable growth Our Business Segments Orthofix manages its business by two reporting segments, Global Spine and Global Orthopedics, which accounted for 84% and 16%, respectively, of our total net sales in 2024. The chart below presents our net sales, which includes product sales and marketing service fees, by reporting segment for each of the years ended December 31, 2024, 2023, and 2022.

Standing Committees; Standing Nominees

| Name                  | Age | Director 
    Since | Independent | Audit &   
 Finance   
 Committee | Compensation           
 and Talent Development 
 Committee              | Compliance 
 & Ethics   
 Committee  | Nominating, Governance & Sustainability Committee |
| Alan L. Bazaar        |  55 |     2023 |            |          |                       |            |                                                   |
| Wayne Burris          |  70 |  2021(1) |            | Chair     |                        |            | 